Credelio Plus RSS Authorised This medicine is authorised for use in the European Union lotilaner / milbemycin oxime Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Credelio Plus Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Credelio Plus : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.97 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (82.44 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (82 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (95.62 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (83.01 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (94.17 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Product information Credelio Plus : EPAR - Product information English (EN) (81.49 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.51 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (92.48 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (81.63 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (81.52 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (81.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (92.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (93.86 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (81.52 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (93.22 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (82.53 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (91.73 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.11 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (81.47 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Credelio Plus : EPAR - All authorised presentations English (EN) (81.94 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View español (ES) (81.97 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View čeština (CS) (93.99 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View dansk (DA) (83.34 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View français (FR) (82.44 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View íslenska (IS) (83.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View italiano (IT) (82.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View magyar (HU) (94.15 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Malti (MT) (95.95 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View norsk (NO) (82 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View polski (PL) (95.62 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View português (PT) (83.01 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View română (RO) (94.17 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Suomi (FI) (81.54 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View svenska (SV) (82.05 KB - PDF) First published: 04/08/2021 Last updated: 11/06/2024 View Product details Name of medicine Credelio Plus Active substance lotilanermilbemycin oxime International non-proprietary name (INN) or common name lotilaner / milbemycin oxime Pharmacotherapeutic groupEndectocides Authorisation details EMA product number EMEA/V/C/005325 Assessment history Expand section Collapse section Changes since initial authorisation of medicine CVMP post-authorisation summary of positive opinion for Credelio PlusAdopted Reference Number: EMA/CVMP/903852/2022 English (EN) (145.39 KB - PDF)First published: 09/12/2022 View Initial marketing authorisation documents Credelio Plus : EPAR - Public assessment reportAdopted Reference Number: EMA/160155/2021 English (EN) (81.49 KB - PDF)First published: 04/08/2021 Last updated: 11/06/2024 View CVMP summary of positive opinion for Credelio PlusAdopted Reference Number: EMA/CVMP/65055/2021 English (EN) (65.98 KB - PDF)First published: 19/02/2021 View News on Credelio Plus Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 202310/11/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 202209/12/2022 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 202213/05/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 202119/02/2021 This page was last updated on 11/06/2024 Share this page